Form4insider filings, from the source

Daily feed · SEC Form 4 filings

Insider buying in low-priced stocks — Dec 3, 2018

Open-market purchases where the filing’s own weighted average price is under $5. Price comes from the Form 4 itself, not a market quote.

39 filings · trading day Dec 3, 2018Download CSVQuotes for these symbols ↗
TradeReported (ET)CompanyInsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Nov 29, 2018 PForm 4 →Nov 30, 4:30 pm ESTvTv Therapeutics Inc.VTVTRonald O Perelman10% Owner1,879,700$1.33$2,500,00112,417,568+17.8% plan?
Nov 29, 2018 PForm 4 →Nov 30, 4:04 pm ESTCorMedix Inc.CRMDJr. John L. ArmstrongExec VP of Tech Operations250,000$1.45$363,150288,861+643% plan?
Nov 28, 2018 PForm 4 →Nov 30, 5:10 pm ESTAVEO PHARMACEUTICALS INCAVEOGrowth Equity Opportunities IV, LLC +310% Owner96,400$1.98$190,89120,164,438+0.48% plan?
Nov 28, 2018 PForm 4 →Nov 30, 5:10 pm ESTAVEO PHARMACEUTICALS INCAVEOPeter J Barris10% Owner96,400$1.98$190,89120,164,438+0.48% plan?
Nov 28, 2018 PForm 4 →Nov 30, 5:11 pm ESTAVEO PHARMACEUTICALS INCAVEOForest Baskett10% Owner96,400$1.98$190,89120,164,438+0.48% plan?
Nov 28, 2018 PForm 4 →Nov 30, 5:11 pm ESTAVEO PHARMACEUTICALS INCAVEOAnthony A. Florence Jr.10% Owner96,400$1.98$190,89120,164,438+0.48% plan?
Nov 28, 2018 PForm 4 →Nov 30, 5:12 pm ESTAVEO PHARMACEUTICALS INCAVEOMohamad Makhzoumi10% Owner96,400$1.98$190,89120,164,438+0.48% plan?
Nov 28, 2018 PForm 4 →Nov 30, 5:12 pm ESTAVEO PHARMACEUTICALS INCAVEOJoshua Makower10% Owner96,400$1.98$190,89120,164,438+0.48% plan?
Nov 28, 2018 PForm 4 →Nov 30, 5:13 pm ESTAVEO PHARMACEUTICALS INCAVEODavid M Mott10% Owner96,400$1.98$190,89120,164,438+0.48% plan?
Nov 28, 2018 PForm 4 →Nov 30, 5:13 pm ESTAVEO PHARMACEUTICALS INCAVEOScott D Sandell10% Owner96,400$1.98$190,89120,164,438+0.48% plan?
Nov 28, 2018 PForm 4 →Nov 30, 5:14 pm ESTAVEO PHARMACEUTICALS INCAVEOPeter W. Sonsini10% Owner96,400$1.98$190,89120,164,438+0.48% plan?
Nov 28, 2018 PForm 4 →Nov 30, 6:28 pm ESTINFINITY PHARMACEUTICALS, INC.INFIBVF PARTNERS L P/IL +610% Owner100,000$1.30$130,0006,510,597+1.56% plan?
Nov 28, 2018 PForm 4 →Nov 30, 9:00 pm ESTAerpio Pharmaceuticals, Inc.ARPOMuneer A SatterDirector, 10% Owner60,000$1.98$118,5245,138,017+1.18% plan?
Nov 30, 2018 PForm 4 →Dec 3, 11:29 am ESTCONTANGO OIL & GAS COMCFJohn C Goff +3Director, 10% Owner24,000$4.07$97,632450,950+5.62% plan?
Nov 28, 2018 PForm 4 →Nov 30, 5:02 pm ESTTRANSATLANTIC PETROLEUM LTD.TATNoah Malone Mitchell IIIChief Executive Officer, Director, 10% Owner97,270$0.9999$97,2631,132,554+9.40% plan?
Nov 28, 2018 PForm 4 →Nov 30, 7:28 pm ESTStealthGas Inc.GASSGlendon Capital Management LP10% Owner15,800$3.58$56,5305,074,585+0.31% plan?
Nov 29, 2018 PForm 4 →Nov 30, 4:19 pm ESTAAC Holdings, Inc.AACW Larry CashDirector25,000$2.23$55,75060,000+71.4% plan?
Nov 29, 2018 PForm 4 →Nov 30, 4:17 pm ESTAAC Holdings, Inc.AACDarrell S. FreemanDirector25,000$2.19$54,75048,052+108% plan?
Nov 28, 2018 PForm 4 →Nov 30, 4:45 pm ESTINNODATA INCINODNauman Sabeeh Toor +110% Owner30,110$1.53$46,169550,000+5.79% plan?
Nov 30, 2018 PForm 4 →Dec 3, 2:34 pm ESTAMPCO PITTSBURGH CORPAPJames J AbelDirector7,000$4.12$28,81826,266+36.3% plan?
Nov 29, 2018 PForm 4 →Dec 3, 11:08 am ESTRAIT Financial TrustRASFNHoward Amster10% Owner8,165$3.43$28,0071,035,841+0.79% plan?
Nov 30, 2018 PForm 4 →Dec 3, 3:06 pm ESTFTE Networks, Inc.FTNWDavid LethemChief Financial Officer5,000$4.79$23,970500,071+1.01% plan?
Nov 28, 2018 PForm 4 →Nov 30, 4:03 pm ESTREPRO MED SYSTEMS INCREPRJoseph M. Manko Jr. +3Director, 10% Owner9,573$1.40$13,4026,757,510+0.14% plan?
Nov 16, 2018 PForm 4 →Dec 3, 12:47 pm ESTMUSTANG BIO, INC.MBIOBrian AchenbachVP, Fin. & Corp. Controller2,500$4.20$10,49757,500+4.55% plan? late
Nov 30, 2018 PForm 4 →Dec 3, 3:43 pm ESTNYMOX PHARMACEUTICAL CORPNYMXJames George RobinsonDirector5,000$1.84$9,2003,270,913+0.15% plan?
Nov 30, 2018 PForm 4 →Dec 3, 7:45 am ESTCONVERSION LABS, INC.CVLBJustin SchreiberChief Executive Officer, Director, 10% Owner30,000$0.1961$5,8833,093,299+0.98% plan?
Nov 29, 2018 PForm 4 →Nov 30, 4:25 pm ESTHunt Companies Finance Trust, Inc.HCFTWilliam A HoulihanDirector1,500$3.50$5,24951,793+2.98% plan?
Nov 21, 2018 PForm 4 →Nov 30, 5:09 pm ESTEVANS & SUTHERLAND COMPUTER CORPESCCPierce TimDirector6,250$0.80$5,00059,097+11.8% plan? late
Nov 29, 2018 PForm 4 →Nov 30, 4:17 pm ESTBioXcel Therapeutics, Inc.BTAIKrishnan NandabalanDirector, 10% Owner1,000$4.92$4,9151,000— plan?
Nov 29, 2018 PForm 4 →Dec 3, 9:39 am ESTTracon Pharmaceuticals, Inc.TCONPuissance Cross-Border Opportunities V LLC +610% Owner4,326$1.13$4,8884,606,094+0.09% plan?
Nov 29, 2018 PForm 4/A →Dec 3, 10:14 am ESTTracon Pharmaceuticals, Inc.TCONPuissance Cross-Border Opportunities V LLC +610% Owner4,326$1.13$4,8884,606,094+0.09% plan?
Dec 3, 2018 PForm 4 →Dec 3, 1:39 pm ESTFTE Networks, Inc.FTNWMichael PalleschiChief Executive Officer, Director898$4.32$3,879800,000+0.11% plan?
Nov 30, 2018 PForm 4 →Dec 3, 11:32 am ESTHEMISPHERX BIOPHARMA INCHEBThomas K. EquelsExec. Vice Chairman/CEO/Pres., Director20,000$0.1922$3,845798,307+2.57% plan?
Nov 30, 2018 PForm 4 →Nov 30, 6:23 pm ESTCellectar Biosciences, Inc.CLRBJames V CarusoPresident and CEO, Director1,000$2.28$2,28222,354+4.68% plan?
Nov 30, 2018 PForm 4 →Dec 3, 12:03 pm ESTRETRACTABLE TECHNOLOGIES INCRVPThomas J ShawPresident and CEO, Director, 10% Owner3,307$0.665$2,19913,754,970+0.02% plan?
Dec 3, 2018 PForm 4 →Dec 3, 3:17 pm ESTKINGSWAY FINANCIAL SERVICES INCKFSJohn Taylor Maloney FitzgeraldCEO and President, Director847$2.46$2,082904,496+0.09% plan?
Dec 3, 2018 PForm 4 →Dec 3, 3:11 pm ESTKINGSWAY FINANCIAL SERVICES INCKFSWilliam August Hickey Jr.CFO, EVP and SEC610$2.46$1,499313,442+0.19% plan?
Dec 3, 2018 PForm 4 →Dec 3, 3:06 pm ESTKINGSWAY FINANCIAL SERVICES INCKFSHassan BaqarVice President406$2.46$998158,768+0.26% plan?
Nov 29, 2018 PForm 4 →Dec 3, 3:26 pm ESTPetrogress, Inc.PGASChristos P TraiosPresident, CEO and CFO, Director, 10% Owner382,841$0.001$3833,198,959+13.6% plan?

A trading day runs to 4:00 pm ET; filings accepted later appear on the next trading day. Rows aggregate a filing’s matching transaction lines — see the methodology for the exact roll-up rules.